BAUM CHARLES M - Insider Non-Derivative Transactions at Mirati Therapeutics, Inc. (MRTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 23, 2024, BAUM CHARLES M's relationship to Mirati Therapeutics, Inc. (MRTX) is Director,Officer (Founder, President, and CEO), and currently has 114,482 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MRTX insiders.
Data Source: SEC.
BAUM CHARLES M - Insider Non-Derivative Transactions of MRTX Common Stock
BAUM CHARLES M - Insider Non-Derivative Transactions at MRTX
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jan 24, 2024 | Disposition -- (Common Stock) | 20425 | 0 | 0 |
Jan 24, 2024 | Disposition -- (Common Stock) | 94057 | 0 | 20425 |
Jan 24, 2024 | Disposition -- (Common Stock) | 123389 | 0 | 114482 |
Dec 30, 2023 | Acquisition -- (Common Stock) | 20425 | 58.75 | 247700 |
Aug 10, 2023 | Acquisition -- (Common Stock) | 54054 | 37 | 227275 |
Jan 21, 2023 | Acquisition -- (Common Stock) | 4444 | 0 | 173221 |
Jan 5, 2023 | Sell -- (Common Stock) | 3648 | 46.6 | 168777 |